Kei Kishimoto

Company: Selecta Biosciences Inc.
Job title: Chief Scientific Officer
Seminars:
Strategizing Methods to Mitigate Against Neutralizing Antibodies in AAV Gene Therapy 2:30 pm
• Leveraging bacterial enzymes to circumvent neutralizing antibodies • Exploring novel approaches to dosing patients with pre-existing immunity • Optimizing neutralizing antibody assays to improve standardizationRead more
day: Day One